Back to compounds

COMPOUND PROFILE / PROTEINS & BIOLOGICS

IGF-1.

Research draft

IGF-1 is an endogenous growth factor; recombinant human IGF-1 is called mecasermin.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Identity and evidence review notes

Confirm exact identity, sequence, alias or formulation before attaching product-specific evidence.

Overview

IGF-1 is an endogenous growth factor; recombinant human IGF-1 is called mecasermin.

CLASSIFICATIONProteins & biologics
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

It activates IGF-1 receptors involved in growth and metabolism.

Human research

Evidence for regulated recombinant products is disease-specific. It cannot establish benefits of unidentified research IGF-1 products.

Preclinical & other research

Cell and animal studies examine growth signalling and tissue responses.

Safety & unknowns

Hypoglycaemia and inappropriate growth signalling are important concerns.

Regulatory status

Mecasermin has a defined prescription indication. Native IGF-1 evidence must not be transferred to IGF-1 LR3.

Reported use & evidence

Research profile draft

The supplied IGF-1 profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds